HURA (TuHURA Biosciences) Other Stockholders Equity : $-0.00 Mil (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is TuHURA Biosciences Other Stockholders Equity?

TuHURA Biosciences's Other Stockholders Equity for the quarter that ended in Sep. 2024 was $-0.00 Mil.

TuHURA Biosciences's quarterly Other Stockholders Equity declined from Mar. 2024 ($-0.00 Mil) to Jun. 2024 ($-0.00 Mil) but then increased from Jun. 2024 ($-0.00 Mil) to Sep. 2024 ($-0.00 Mil).

TuHURA Biosciences's annual Other Stockholders Equity declined from Dec. 2021 ($-0.00 Mil) to Dec. 2022 ($-0.00 Mil) but then increased from Dec. 2022 ($-0.00 Mil) to Dec. 2023 ($-0.00 Mil).

TuHURA Biosciences Other Stockholders Equity Historical Data

The historical data trend for TuHURA Biosciences's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TuHURA Biosciences Other Stockholders Equity Chart

TuHURA Biosciences Annual Data

Trend

Dec21

Dec22

Dec23

Other Stockholders Equity

TuHURA Biosciences Quarterly Data
	Dec21	Mar22	Dec22	Mar23	Dec23	Mar24	Jun24	Sep24
Other Stockholders Equity	Get a 7-Day Free Trial			-	-	-	-	-

TuHURA Biosciences Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

TuHURA Biosciences Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of TuHURA Biosciences's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

TuHURA Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TuHURA Biosciences Inc (NAS:HURA) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

10500 University Center Drive, Suite 110, Tampa, FL, USA, 33612

Website

https://www.tuhurabio.com

TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.